EGFR and idiopathic pulmonary fibrosis: As one of the ERBB family genes, the role of ERBB4 in fibrosis of various organs has been emphasized (Vermeulen et al., 2017), and it has been considered a potential drug target for treating IPF (Higo et al., 2022).